GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYZF) » Definitions » COGS-to-Revenue

Bayer AG (Bayer AG) COGS-to-Revenue : 0.38 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Bayer AG COGS-to-Revenue?

Bayer AG's Cost of Goods Sold for the three months ended in Dec. 2023 was $4,892 Mil. Its Revenue for the three months ended in Dec. 2023 was $12,936 Mil.

Bayer AG's COGS to Revenue for the three months ended in Dec. 2023 was 0.38.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Bayer AG's Gross Margin % for the three months ended in Dec. 2023 was 62.18%.


Bayer AG COGS-to-Revenue Historical Data

The historical data trend for Bayer AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG COGS-to-Revenue Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.46 0.38 0.39 0.41

Bayer AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.40 0.43 0.47 0.38

Bayer AG COGS-to-Revenue Calculation

Bayer AG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=21536.532 / 51948.746
=0.41

Bayer AG's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4892.039 / 12935.66
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bayer AG  (OTCPK:BAYZF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Bayer AG's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 4892.039 / 12935.66
=62.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Bayer AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bayer AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (Bayer AG) Business Description

Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.